ACPE Renews Accreditation of PharmD Degree Program through 2031

The Accreditation Council for Pharmacy Education (ACPE) has granted renewed accreditation for the USC Mann School of Pharmacy and Pharmaceutical Sciences’s Doctor of Pharmacy (PharmD) degree program for eight years, through June 30, 2031.

ACPE—recognized by the U.S. Department of Education as the national agency for the accreditation of professional degree programs in pharmacy—found the School to be compliant with all 25 of its standards.

As part of the accreditation review process, the School conducted a comprehensive self-study of its four-year PharmD program. An on-site evaluation, which took place March 7-9, 2023 with an ACPE-trained site team of five members, consisted of interviews with faculty, staff and students.

According to ACPE, accreditation actions are based on self-studies, comprehensive and focused evaluations, communications received from the institutions, ongoing annual review of North American Pharmacist Licensure Examination (NAPLEX) passing rates, entry class size, and attrition and on-time graduation rates, among other factors.

Dean Vassilios Papadopoulos thanked all members of the USC Mann community—students, faculty, staff, alumni and others—who participated in the intensive self-study process. “Our eight-year reaccreditation reflects the strength of our PharmD program, our shared commitment to our mission, and our ongoing growth as an academic community,” Papadopoulos said.